Adam Hakim-Al
Leeds, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS-DAI).
Journal: Arthritis care & research
Published: March 05, 2026
VEXAS syndrome and immune-mediated rheumatic diseases: overlaps in clinical features and mechanisms.
VEXAS syndrome and immune-mediated rheumatic diseases: overlaps in clinical features and mechanisms.
Journal: The Lancet. Rheumatology
Published: March 09, 2025
Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general population.
Journal: British journal of haematology
Published: February 19, 2025
Clinical features in VEXAS syndrome: a systematic review.
Journal: Rheumatology (Oxford, England)
Published: February 07, 2025
Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort study.
Journal: The Lancet. Rheumatology
Published: December 05, 2024
Sequelae of B-Cell Depleting Therapy: An Immunologist's Perspective.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: November 27, 2024
The Scope and Impact of Viral Infections in Common Variable Immunodeficiency (CVID) and CVID-like Disorders: A Literature Review.
Journal: Journal of clinical medicine
Published: February 07, 2024
S56F UBA1 variant is associated with haematological predominant subtype of VEXAS.
Journal: British journal of haematology
Published: June 13, 2023
Recovery of Bone Marrow Function in VEXAS Syndrome-potential Role for Romiplostim.
Journal: HemaSphere
Published: April 11, 2023
An update on VEXAS syndrome.
Journal: Expert review of clinical immunology
Published: December 20, 2022
Allogeneic haematopoietic stem cell transplantation for VEXAS syndrome: UK experience.
Journal: British journal of haematology
Published: August 10, 2022
Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience.
Journal: Frontiers in immunology
Published: July 01, 2022
Last Updated: 09/26/2026